These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4338344)

  • 21. Hyporeactivity to interferon production by double-stranded RNA associated with hyporeactivity to antiviral protection and hyporeactivity to toxicity.
    De Clercq E
    Proc Soc Exp Biol Med; 1972 Oct; 141(1):340-5. PubMed ID: 4343194
    [No Abstract]   [Full Text] [Related]  

  • 22. Circulating interferon in mice infected with the lactate dehydrogenase-elevating virus.
    Evans R; Riley V
    J Gen Virol; 1968 Dec; 3(3):449-52. PubMed ID: 4304104
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses.
    Gresser I; Tovey MG; Maury C; Bandu MT
    J Exp Med; 1976 Nov; 144(5):1316-23. PubMed ID: 186555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of an interferon-like agent following inoculation with bacterial vaccine.
    Degre M; Dahl H
    Proc Soc Exp Biol Med; 1971 May; 137(1):233-6. PubMed ID: 4325773
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of individual spleen cells in the interferon response of the intact mouse.
    Osborn JE; Walker DL
    Proc Natl Acad Sci U S A; 1969 Apr; 62(4):1038-45. PubMed ID: 4307872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective binding of human interferon to albumin immoblized on agarose.
    Huang JW; Davey MW; Hejna CJ; Von Muenchhausen W; Sulkowski E; Carter WA
    J Biol Chem; 1974 Jul; 249(14):4665-7. PubMed ID: 4367221
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence and production of interferon in Rauscher virus infected mice.
    Vandeputte M; De Lafonteyne J; Billiau A; De Somer P
    Arch Gesamte Virusforsch; 1967; 20(2):235-45. PubMed ID: 4299728
    [No Abstract]   [Full Text] [Related]  

  • 28. Interferon in experimental viral infections in mice: tissue interferon levels resulting from the virus infection and from exogenous interferon therapy.
    Heremans H; Billiau A; De Somer P
    Infect Immun; 1980 Nov; 30(2):513-22. PubMed ID: 6160109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of tissue viral resistance in chickens following administration of interferon inducers.
    Finkelstein MS
    J Immunol; 1972 Jun; 108(6):1506-16. PubMed ID: 4337965
    [No Abstract]   [Full Text] [Related]  

  • 30. Growth of Newcastle disease and herpes virus and interferon production in a monkey-mouse hybrid line.
    Coppey J
    J Gen Virol; 1972 Jan; 14(1):9-14. PubMed ID: 4334778
    [No Abstract]   [Full Text] [Related]  

  • 31. Poly I:C, an inducer of interferon and interference against virus infections.
    Field AK; Tytell AA; Piperno E; Lampson GP; Nemes MM; Hilleman MR
    Medicine (Baltimore); 1972 May; 51(3):169-74. PubMed ID: 4336643
    [No Abstract]   [Full Text] [Related]  

  • 32. Le interferon production by human fibroblasts.
    Hayes TG; Yip YK; Vilcek J
    Virology; 1979 Oct; 98(2):351-63. PubMed ID: 228476
    [No Abstract]   [Full Text] [Related]  

  • 33. [Interferon-producing activity of bone marrow cells treated with mRNA for interferon when transplanted to irradiated mice].
    Orlova TG; Zhdanova LV; Mentkevich LM; Shcheglovitova ON; Solov'ev VD
    Vopr Virusol; 1979; (5):541-4. PubMed ID: 228497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of animal genotype and age on the amount of circulating interferoh induced by Newcastle disease virus.
    De Maeyer E; De Maeyer-Guignard J
    J Gen Virol; 1968 May; 2(3):445-9. PubMed ID: 4300106
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunoferon (AM3) enhances the activities of early-type interferon inducers and natural killer cells.
    Moya P; Baixeras E; Barasoain I; Rojo JM; Ronda E; Alonso ML; Portolés A
    Immunopharmacol Immunotoxicol; 1987; 9(2-3):243-56. PubMed ID: 2449486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mouse macrophage interferons].
    Mentkevich LM; Churbakova EV
    Vopr Virusol; 1981; (4):410-4. PubMed ID: 6171097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rabbit macrophage interferons. I. Conditions for biosynthesis by virus-infected and uninfected cells.
    Smith TJ; Wagner RR
    J Exp Med; 1967 Apr; 125(4):559-77. PubMed ID: 4163879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survey of interferon production and sensitivity human cell lines.
    Moehring JM; Stinebring WR; Merchant DJ
    Appl Microbiol; 1971 Jul; 22(1):102-5. PubMed ID: 4329429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of the efficacy of different forms of interferon therapy in the treatment of mice challenged intranassaly with vesicular stomatitis virus (VSV).
    De Clercq E; De Somer P
    Proc Soc Exp Biol Med; 1971 Oct; 138(1):301-7. PubMed ID: 4331092
    [No Abstract]   [Full Text] [Related]  

  • 40. Age-related cellular resistance of the chicken embryo to viral infections. I. Interferon and natural resistance to myxoviruses and vesicular stomatitis virus.
    Morahan PS; Grossberg SE
    J Infect Dis; 1970 Jun; 121(6):615-23. PubMed ID: 4316147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.